China’s ambitious healthcare reforms lure India’s biggest drug maker

The Sun Pharmaceutical Industries Ltd. headquarters stand in Mumbai, India, on Thursday, May 2, 2019. Photographer: Kanishka Sonthalia/Bloomberg

Sun Pharmaceutical Industries Ltd. is scouting for a partner in China to help it win a larger piece of the world’s second-largest drug market, where the government is on a mission to drive down the cost of healthcare.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.